Sirtuins

Cat. No.

A10862

CAS No.

1001645-58-4

SRT1720 HCl

Synonyms: SRT-1720

SRT1720 is an inhibitor developed intended as a small-molecule activator of the sirtuin subtype SIRT1.

Cat. No.

A14188

CAS No.

1093403-33-8

SRT2104 (GSK2245840)

Synonyms: GSK2245840

SRT2104 (GSK2245840) is a selective SIRT1 activator involved in the regulation of energy homeostasis. Phase 2.

Cat. No.

A12305

CAS No.

1011557-82-6

Tenovin-6

Tenovin-6 is a analog of tenovin-1. Tenovin-6 inhibits the protein deacetylase activities of purified human SIRT1, SIRT2, and SIRT3 in vitro with IC50 values of 21, 10, and 67 uM, respectively.

Cat. No.

A15247

CAS No.

925434-55-5

SRT 1720

SRT 1720 is a selective activator of human SIRT1 (EC1.5 = 0.16 μM) versus the closest sirtuin homologues, SIRT2 and SIRT3 (SIRT2: EC1.5 = 37 uM; SIRT3: EC1.5 > 300 uM).

Cat. No.

A12150

CAS No.

1001908-89-9

SRT 2183

SRT 2183 is a selective Sirtuin-1 (SIRT1) activator with an EC1.5 value of 0.36 μM. SRT 2183 induces growth arrest and apoptosis, concomitant with deacetylation of STAT3 and NF-κB, and reduction of c-Myc protein levels.

Cat. No.

A17228

CAS No.

2275619-53-7

MDL-800

MDL-800 is a first-in-class cellularly active SIRT6 allosteric activator.

Cat. No.

A18961

CAS No.

358721-70-7

UBCS039

UBCS039 is the first synthetic, specific Sirtuin 6 (SIRT6) activator, inducing autophagy in human tumor cells, with an EC50 of 38 μM.

Cat. No.

A19026

CAS No.

925432-73-1

SRT 1460

SRT 1460, a potent Sirtuin-1 (SIRT1) activator with an EC1.5 value of 2.9 μM, shows good selectivity for activation of SIRT1 versus SIRT2 and SIRT3 (EC1.5>300 μM), and is more potent than Resveratrol and the closest sirtuin homologues.

Cat. No.

A19395

CAS No.

374922-43-7

CAY10602

CAY10602 is a SIRT1 activator.

Cat. No.

A21143

CAS No.

2060259-60-9

SRT 1720 Hydrochloride

Synonyms: SRT1720

SRT 1720 Hydrochloride is a selective activator of SIRT1 with an EC50 of 0.10 μM, and shows less potent activities on SIRT2 and SIRT3.

Cat. No.

A26728

CAS No.

120533-76-8

BML-278

BML-278 is a potent SIRT1 activator with an effective concentration (EC150) of 1 μM. It enhances histone modifications by increasing H3K9 methylation and inhibiting H3K9 acetylation, which contributes to improved early embryonic development. Additionally, BML-278 induces G1/S phase cell cycle arrest and reduces senescence in primary human mesenchymal cells. In U937 cells, this compound reduces tubulin acetylation while promoting increased mitochondrial density in murine C2C12 myoblasts, highlighting its versatility in cellular and developmental research applications.

Cat. No.

A30339

CAS No.

2601734-99-8

SIRT6 activator 12q

SIRT6 activator 12q is a potent and selective small molecule that acts as an activator of SIRT6, exhibiting an IC50 of 0.58 μM, while demonstrating much lower activity against other sirtuins such as SIRT1-3 and SIRT5. This compound has been shown to inhibit cell growth and migration, induce apoptosis, and cause cell cycle arrest at the G2 phase. With its potential anticancer properties, SIRT6 activator 12q is a valuable tool for research in cancer biology and therapeutic development targeting SIRT6 pathways.

Cat. No.

A30905

CAS No.

33606-81-4

Myricanol

Myricanol is a diarylheptanoid that acts as a Nampt activator, enhancing SIRT1 and PRDX5 activities. This compound exhibits notable anti-inflammatory properties and mitigates glucocorticoid-induced muscle atrophy while regulating inflammatory mediators. Additionally, it demonstrates growth inhibition and promotes apoptosis in human lung adenocarcinoma A549 cells. Myricanol is also implicated in neuroprotection via autophagy-mediated clearance of microtubule-associated protein tau and contributes to cardiovascular health by inhibiting key signaling pathways such as PDGFRβ and NF-κB. Its activation of mitochondrial transcription factor A (TFAM) further supports anti-renal fibrosis effects and improves insulin sensitivity through AMPK activation.

Cat. No.

A35844

CAS No.

2275619-98-0

MDL-811

MDL-811 is a selective allosteric activator of SIRT6, exhibiting an EC50 of 5.7 μM. This compound demonstrates significant anti-inflammatory, antitumor, and neuroprotective properties, making it a valuable tool for research. MDL-811 is particularly relevant for studies related to colorectal cancer and ischemic stroke, providing insights into potential therapeutic strategies targeting SIRT6 modulation.

Cat. No.

A39359

CAS No.

2468639-77-0

SRT 1720 dihydrochloride

SRT 1720 dihydrochloride is a selective activator of SIRT1, exhibiting an EC50 of 0.10 μM. This compound demonstrates lower activity toward SIRT2 and SIRT3, making it an important tool for investigating SIRT1-related biological pathways. Its ability to modulate SIRT1 activity is particularly relevant in studies of metabolism, aging, and neuroprotection.

Cat. No.

A53869

CAS No.

1384897-64-6

Altissimacoumarin F

Altissimacoumarin F is a terpenylated coumarin that acts as an activator of SIRT1, a protein implicated in cellular stress response and longevity. This compound, isolated from the stem bark of Ailanthus altissima, enhances SIRT1 activity while simultaneously decreasing p53 transcriptional activity. Altissimacoumarin F is valuable for research into age-related disorders and related pathways, providing insights into potential therapeutic strategies.

Cat. No.

A56947

CAS No.

500271-63-6

2-APQC

2-APQC is a selective activator of Sirtuin-3 (SIRT3), exhibiting an affinity of Kd=2.756 μM. This compound enhances mitochondrial proline metabolism through the SIRT3-PYCR1 axis and mitigates ROS-induced cytotoxicity by inhibiting the mTOR-p70S6K, JNK, and TGF-β/Smad3 signaling pathways. Additionally, 2-APQC activates the AMPK-Parkin axis, providing a protective effect against myocardial hypertrophy and fibrosis, making it a valuable tool for researching heart failure and related cardiac dysfunctions.

Cat. No.

A56949

CAS No.

782387-91-1

ADTL-SA1215

ADTL-SA1215 is a novel small-molecule activator of SIRT3, targeting the regulation of autophagy pathways. This compound has demonstrated potential in inducing autophagy in triple-negative breast cancer cells, presenting opportunities for cancer research and therapeutic development. Its specificity for SIRT3 makes it an essential tool for studying the role of sirtuins in cellular metabolism and cancer progression.

Cat. No.

A56958

CAS No.

3061491-60-6

SIRT3 activator 2

SIRT3 Activator 2 is a selective activator of the SIRT3 enzyme. This compound enhances the thermal stability of SIRT3 in SH-SY5Y cells through direct binding, facilitating the clearance of α-synuclein in a SIRT3-dependent manner. In vivo studies demonstrate that SIRT3 Activator 2 improves motor function in Parkinson’s disease models and prevents the loss of dopamine neurons in the substantia nigra in a dose-dependent fashion, making it a valuable tool for research into neurodegenerative disorders.

Cat. No.

A56959

CAS No.

556743-18-1

Lumbokinase

Lumbokinase is a Sirt1 activator that plays a crucial role in mitigating myocardial ischemia-reperfusion (I-R) injury. By enhancing Sirt1 signaling, it promotes autophagic flux while simultaneously reducing oxidative damage, inflammation, and apoptosis associated with I-R events. This compound is valuable for research applications focused on cardiac protection, autophagy modulation, and the underlying mechanisms of ischemic injury.

Cat. No.

A56960

CAS No.

2070015-26-6

Sirtuin modulator 1

Sirtuin Modulator 1 is a selective modulator of SIRT1, a member of the sirtuin family of NAD+-dependent deacetylases. With an effective concentration of less than 1 μM, it demonstrates significant biological activity in the regulation of cellular aging and metabolism. This reagent holds potential for research applications in studying age-related diseases, metabolic disorders, and the mechanisms of epigenetic regulation mediated by sirtuins.

Cat. No.

A56962

CAS No.

1031195-19-3

E1231

Synonyms: 1-{4-[2-(5-Methylfuran-2-yl)quinoline-4-carbonyl]piperazin-1-yl}ethan-1-one

E1231 is a potent activator of Sirtuin 1 (SIRT1), exhibiting an EC50 of 0.83 μM. This compound enhances cholesterol and lipid metabolism by interacting with SIRT1 (KD = 9.61 μM) and promoting the deacetylation of liver X receptor-alpha (LXRα), which subsequently increases the expression of ATP-binding cassette transporter A1 (ABCA1). Additionally, E1231 has demonstrated efficacy in reducing atherosclerotic plaque development in ApoE-/- mouse models, making it a valuable tool for research into lipid disorders and related diseases.

Cat. No.

A56971

CAS No.

476633-98-4

Sirtuin modulator 6

Sirtuin modulator 6 is a selective modulator of sirtuin proteins, known for its role in enhancing cellular longevity. This compound exhibits potential therapeutic effects in the context of metabolic disorders such as diabetes and obesity, as well as neurodegenerative and cardiovascular diseases. Its mechanism of action supports research into the modulation of sirtuin pathways, providing insights into various age-related health conditions.

Cat. No.

A56973

CAS No.

925437-38-3

Sirtuin modulator 8

Sirtuin modulator 8 is an effective activator of sirtuin proteins, demonstrating the capacity to enhance sirtuin activity. This compound significantly reduces the expression of monocyte chemoattractant protein-1 (MCP-1) while increasing fibroblast growth factor 21 (FGF21) levels. By regulating genes associated with inflammation and metabolism, Sirtuin modulator 8 is a valuable tool for researching metabolic disorders such as diabetes and obesity, as well as inflammatory diseases.

Cat. No.

A56977

CAS No.

1215281-19-8

YK-3-237

YK-3-237 is a selective activator of SIRT1, targeting mutant p53 proteins. This compound has demonstrated the ability to inhibit the proliferation of triple-negative breast cancer cells, making it a valuable tool for research into cancer biology and potential therapeutic strategies. It may provide insights into the role of SIRT1 in tumor progression and cellular metabolism.